Tag: Kidney Problems: Misc.
Canagliflozin Reduces Cardiorenal Biomarkers in T2D
Increase in biomarkers and multimarker panel linked to increased risk for primary cardiorenal outcome
Budesonide Yields Durable Reduction in eGFR for IgA Nephropathy
Clinically relevant reduction in eGFR seen over two years with targeted release formulation of budesonide
Improved Outcomes Seen With Lower 2021 KDIGO BP Target
Risk for composite kidney outcome reduced with lower 2021 KDIGO BP target versus 2012 KDIGO target
Higher Plant Protein Intake Tied to Lower Risk for Chronic Kidney Disease
Finding persists whether kidney disease is based on diagnostic code or laboratory measurements
Promising Outcomes Seen for Living Kidney Donors With HIV
Glomerular filtration rates decreased at two to four years of follow-up for the first three living kidney donors with HIV
Voclosporin Safe, Effective for Long-Term Treatment of Lupus Nephritis
Benefits include maintenance of urine protein creatinine ratio reductions, preserved kidney function
Small Link Seen for Acute Kidney Injury, Worsening of Kidney Function in CKD
In fully adjusted models, decreases in eGFR based on serum creatinine level or cystatin C levels were small
ADA: Childhood Hyperglycemia Linked to Future Microvascular Complications
Higher HbA1c, two-hour plasma glucose linked to significantly increased risk of retinopathy in children without T2D
Modest Decrease in eGFR Linked to Increase in Adverse Outcomes
Findings in adults with no history of kidney disease; adverse outcomes were higher for those aged 18 to 39 years
Collaborative Care Cuts Fatigue, Pain in ESKD Hemodialysis Patients
Beneficial effects seen for 12 weekly sessions of cognitive behavioral therapy and/or pharmacotherapy using stepped approach
